Search bioRxiv⌕ Search

Biology subjects

Sanchez, M. F.

Publications and source records attributed to Sanchez, M. F..

2 recordsLinked to original sources

Dynamic in situ confinement triggers ligand-free neuropeptide receptor signaling

Membrane receptors are central to cell-cell communication. Receptor clustering at the plasma membrane modulates physiological responses, and mesoscale receptor organization is critical for downstream signaling. Spatially restricted cluster formation of the neuropeptide Y2 hormone receptor (Y2R) was observed in vivo; however, the relevance of this confinement is not fully understood. Here, we controlled Y2R clustering in situ by a chelator nanotool. Due to the multivalent interaction, we observed a dynamic exchange in the microscale confined regions. Fast Y2R enrichment in clustered areas triggered a ligand-independent downstream signaling determined by an increase in cytosolic calcium, cell spreading, and migration. We revealed that the cell response to ligand-induced activation was amplified when cells were pre-clustered by the nanotool. Ligand-independent signaling by clustering differed from ligand-induced activation in the binding of arrestin-3 as downstream effector, which was recruited to the confined regions only in the presence of the ligand. This approach enables in situ clustering of membrane receptors and raises the possibility to explore different modalities of receptor activation. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=93 SRC="FIGDIR/small/472742v2_ufig1.gif" ALT="Figure 1"> View larger version (43K): org.highwire.dtl.DTLVardef@9c7823org.highwire.dtl.DTLVardef@93660corg.highwire.dtl.DTLVardef@110c414org.highwire.dtl.DTLVardef@1b906d3_HPS_FORMAT_FIGEXP M_FIG C_FIG

biophysics↗

Aβ promotes amyloidogenic processing of APP through a Go/Gβγ signaling

Alzheimers disease (AD) is characterized by a cognitive impairment associated to amyloid beta (A{beta}) aggregation and deposition in the brain. A{beta} is generated by sequential cleavage of the amyloid precursor protein (APP) by {beta}-site APP cleaving enzyme 1 (BACE1) and {gamma}-secretase complex. The mechanisms that underlie exacerbated production of A{beta}, favoring its deposition in the brain, is largely unknown. In vitro studies have shown that A{beta} aggregates trigger enhanced production of A{beta} by a yet non described mechanism. Here, we show that in different cell types, including human neurons derived from induced pluripotent stem cells (iPSC), oligomers and fibrils of A{beta} enhance the convergence and interaction of APP and BACE1 in endosomal compartments. We demonstrated a key role of A{beta}-APP/Go/G{beta}{gamma} signaling on the amyloidogenic processing of APP. We show that APP mutants with impaired capacity to bind A{beta} or to activate Go protein, are unable to exacerbate APP and BACE1 colocalization in the presence of A{beta}. Moreover, pharmacological inhibition of G{beta}{gamma} subunits signaling with gallein, abrogate A{beta}-dependent interaction of APP and BACE1 in endosomes preventing {beta}-processing of APP. Collectively, these findings uncover a feed-forward mechanism of amyloidogenesis that might contribute to A{beta} pathology in early stages of AD and suggest that gallein might have clinical relevance.

neuroscience↗